• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAllergan

Allergan

Page 4 of 6
Pfizer CEO Ian Read
FinancePfizer Says No Merger Tax Help For Our Top Execs
By Dan PrimackNovember 25, 2015
Pfizer CEO Ian Read
LeadershipPfizer’s CEO Isn’t a Hero or a Villain
By Geoff ColvinNovember 25, 2015
Pfizer In Merger Talks With Allergan PLC
FinancePfizer’s Allergan Deal is an Even Bigger Tax Dodge Than It’s Claiming
By Stephen GandelNovember 24, 2015
Pfizer In Merger Talks With Allergan PLC
FinanceInvestors Aren’t Convinced the Pfizer-Allergan Deal is a Go
By Stephen GandelNovember 23, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
FinanceWill the Pfizer Inversion Get It Booted From the Dow?
By Chris MatthewsNovember 23, 2015
Pfizer In Merger Talks With Allergan PLC
FinancePfizer/Allergan deal pushes 2015 into the record books
By Dan PrimackNovember 23, 2015
HealthPrediction: Healthcare’s M&A Flood Will Ebb in 2016
By Jen WiecznerNovember 23, 2015
Pfizer In Merger Talks With Allergan PLC
HealthPfizer, Allergan Confirm $160 Billion Merger Deal
By Geoffrey Smith and Claire GrodenNovember 23, 2015
Pfizer In Merger Talks With Allergan PLC
LeadershipPfizer, Allergan Poised for $150 Billion Merger
By Claire GrodenNovember 22, 2015
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
FinanceWhy New Tax Inversion Rules Won’t Stop Pfizer-Allergan Deal
By Stephen GandelNovember 20, 2015
Pfizer In Merger Talks With Allergan PLC
LeadershipWill Lobbying Dollars Put Pfizer and Allergan On The Fast Track?
By Paul HodgsonNovember 20, 2015
Pfizer employees inside of a laboratory at Pfizer's research and development facility in Cambridge, Massachusetts, U.S., on Monday, Oct. 26, 2015. Photographer: Scott Eisen/Bloomberg *** Local Caption ***
FinanceWhy Pfizer Is Headed for Splitsville After Allergan Merger
By Jen WiecznerNovember 19, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
LeadershipA Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By Alan MurrayNovember 19, 2015
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
FinanceWhy Mylan Just Lost The Largest Hostile Takeover Battle Ever
By Jen WiecznerNovember 13, 2015
Bill Ackman
HealthValeant, Ackman Must Face U.S. Insider Trading Lawsuit
By ReutersNovember 11, 2015
1
  • 2
  • 3
  • 4
  • 5
  • 6
6
Most Popular
C-Suite
OpenAI’s Sam Altman says his highly disciplined daily routine has ‘fallen to crap’—and now unwinds on weekends at a ranch with no cell phone serviceAn image of a popular article
By Jacqueline MunisFebruary 5, 2026
Politics
Meet the Palm Beach billionaire who paid $2 million for a private White House visit with TrumpAn image of a popular article
By Tristan BoveFebruary 3, 2026
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.